TP53 and neoplasm: This result is consistent with our previous report demonstrating miR‐34c's direct inhibition of Notch signaling during physiological osteoblast differentiation.(22) Given that miR‐34c is a downstream effector of p53 and an upstream negative regulator of Notch signaling, we hypothesized that miR‐34c plays a tumor suppressive role in OS progression.